Use Of Arvs In Patients With Cryptococcal

Patients initiating ART with undiagnosed cryptococcal disease are at higher risk of early mortality than patients who are pre-emptively diagnosed and treated for cryptococcal disease. All patients initiating ART should be clinically screened for evidence of symptomatic cryptococcal disease — headache, neck stiffness, fever, focal neurologic signs, confusion, and altered mental status. All those who screen positive should be referred for further diagnostic work up for meningitis. Screening of asy

Chapter 9: Antiretroviral Therapy

Treatments

1 drug
Other
Preg. Unknown

Indication: Use Of Arvs In Patients With Cryptococcal

Adult Dose

200mg

Route

oral

Frequency

daily

Duration

6 months